Clinical Trial Update: Mecillinam for Treatment of Genital Chlamydia Infection [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating mecillinam for chlamydial infections, including genital Chlamydia trachomatis infection and chlamydial urethritis, was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chlamydia Trachomatis Infection
• Chlamydial Urethritis

Drugs mentioned

• Mecillinam (mecillinam)

Snippet

Sponsor: Oslo University Hospital | Conditions: Chlamydia Trachomatis Infection, Chlamydial Urethritis | Phase 2 | Status: TERMINATED